Cargando…
Polymeric human Fc-fusion proteins with modified effector functions
The success of Fc-fusion bio-therapeutics has spurred the development of other Fc-fusion products for treating and/or vaccinating against a range of diseases. We describe a method to modulate their function by converting them into well-defined stable polymers. This strategy resulted in cylindrical h...
Autores principales: | Mekhaiel, David N. A., Czajkowsky, Daniel M., Andersen, Jan Terje, Shi, Jianguo, El-Faham, Marwa, Doenhoff, Michael, McIntosh, Richard S., Sandlie, Inger, He, Jianfeng, Hu, Jun, Shao, Zhifeng, Pleass, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216605/ https://www.ncbi.nlm.nih.gov/pubmed/22355641 http://dx.doi.org/10.1038/srep00124 |
Ejemplares similares
-
Fc-fusion proteins: new developments and future perspectives
por: Czajkowsky, Daniel M, et al.
Publicado: (2012) -
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
por: Czajkowsky, Daniel M., et al.
Publicado: (2015) -
The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019) -
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity
por: Foss, Stian, et al.
Publicado: (2015) -
Human and mouse albumin bind their respective neonatal Fc receptors differently
por: Nilsen, Jeannette, et al.
Publicado: (2018)